Can the fund management industry deliver a better deal for investors?

IMAGINE an industry where the average profit margins were 36%, where the regulator found little evidence of price competition and where the average person did not get the benefit of the lower charges available to the wealthiest customers. You would probably expect the...

‘Pharma bro’ Shkreli’s trial hits a rough patch as the court struggles to pick a pool of jurors

Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging hit a rough patch on Tuesday as the court struggled to pick a pool of prospective jurors who could ignore a swirl of bad publicity for the defendant. A third day of...